Intensity Therapeutics Common Stock Analysis

Intensity Stock Analysis Notes

The book value of the company was currently reported as 0.15. The company recorded a loss per share of 13.75. Intensity Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 19th of February 2026. To learn more about Intensity Therapeutics Common call the company at 203 221 7381 or check out https://www.intensitytherapeutics.com.

Intensity Therapeutics Investment Alerts

Intensity Largest EPS Surprises

View All Earnings Estimates

Intensity Therapeutics Environmental, Social, and Governance (ESG) Scores

Intensity Stock Institutional Investors

Note, although Intensity Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Intensity Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 367.64 M.

Intensity Profitablity

Management Efficiency

Intensity Therapeutics has return on total asset (ROA) of (1.0166) % which means that it has lost $1.0166 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.347) %, meaning that it created substantial loss on money invested by shareholders. Intensity Therapeutics' management efficiency ratios could be used to measure how well Intensity Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -4.11 in 2026. Return On Capital Employed is likely to gain to -5.98 in 2026. At this time, Intensity Therapeutics' Total Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 1.6 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 929.9 K in 2026.

Technical Drivers

As of the 19th of February, Intensity Therapeutics retains the Market Risk Adjusted Performance of 0.9125, risk adjusted performance of 0.1026, and Downside Deviation of 7.95. Intensity Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Intensity Therapeutics information ratio and downside variance to decide if Intensity Therapeutics is priced fairly, providing market reflects its last-minute price of 6.52 per share. Given that Intensity Therapeutics Common has jensen alpha of 33.36, we strongly advise you to confirm Intensity Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Intensity Therapeutics Price Movement Analysis

Intensity Therapeutics Insider Trading Activities

Intensity Therapeutics Outstanding Bonds

Intensity Therapeutics Predictive Daily Indicators

Intensity Therapeutics Corporate Filings

Intensity Therapeutics Forecast Models

Intensity Therapeutics' time-series forecasting models are one of many Intensity Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Intensity Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Intensity Therapeutics Bond Ratings

Intensity Therapeutics Common financial ratings play a critical role in determining how much Intensity Therapeutics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Intensity Therapeutics' borrowing costs.

Intensity Therapeutics Total Assets Over Time

Intensity Therapeutics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Intensity Therapeutics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Intensity Therapeutics Debt Ratio

2.47

It appears most of the Intensity Therapeutics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Intensity Therapeutics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Intensity Therapeutics, which in turn will lower the firm's financial flexibility.

Intensity Therapeutics Corporate Bonds Issued

Intensity Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Intensity Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intensity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Intensity Therapeutics. By using and applying Intensity Stock analysis, traders can create a robust methodology for identifying Intensity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Intensity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Intensity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Intensity Therapeutics Common stock analysis indicators help investors evaluate how Intensity Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Intensity Therapeutics shares will generate the highest return on investment. By understating and applying Intensity Therapeutics stock analysis, traders can identify Intensity Therapeutics position entry and exit signals to maximize returns.

When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.